Household’s Catastrophic Health Expenditure in Patients With Type 2 Diabetes: A Study From Iran
Health Technology Assessment in Action · 05.08.2026
DOI: 10.18502/htaa.v10i2.22222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Technology Assessment in Action, online erschienen am 05.08.2026. Verfasst von Shahryar Sadr Manouchehri und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Type 2 diabetes (T2D) is a chronic condition that substantially threatens public health due to its prevalence and severe adverse effects. Beyond its health consequences, T2D is associated with considerable financial burden. Accordingly, this study aimed to investigate the magnitude and determinants of catastrophic health expenditure (CHE) incurred by patients with T2D.
Methods
Overall, 400 participants with T2D participated in this cross-sectional study in 2022, and a researcher-made questionnaire was used for data collection. The allocation of at least 40% of non-food expenditures to healthcare (during the last year) was the basis for CHE calculation. The chi-square test was utilized to determine the statistical association between demographic and background variables and CHE occurrence.
Results
It was found that patients incur a mean annual cost of $1138, including 15.5%, 8.5%, and 76% spent on diagnostic expenses, medical visits, and treatment expenditures, respectively. Laboratory services, internist and endocrinologist visits, and medication accounted for the most considerable proportion of diagnostic, physician visits, and treatment costs. About 19.95% of direct medical costs were attributable to non-food costs, while 13.5% of patients experienced CHE. Educational status, employment status, indigenousness, residency in urban and rural areas, supplementary health insurance, disease treatment, the location of getting care, and the statistically significant link between the side effects and occurrence of CHE were among the demographic and background variables.
Conclusion
Although the rate of CHE provided care to diabetic patients is reasonable, health policymakers still need to take steps to resolve the situation through promotion measures.
Zitieren
APA
Manouchehri, S. S., Kassaeian, S. S., Danaei, N., & Gharibi, F. (2026). Household’s Catastrophic Health Expenditure in Patients With Type 2 Diabetes: A Study From Iran. Health Technology Assessment in Action. https://doi.org/10.18502/htaa.v10i2.22222
Vancouver
Manouchehri SS, Kassaeian SS, Danaei N, Gharibi F. Household’s Catastrophic Health Expenditure in Patients With Type 2 Diabetes: A Study From Iran. Health Technology Assessment in Action. 2026. doi:10.18502/htaa.v10i2.22222
BibTeX
@article{Manouchehri2026,
author = {Manouchehri, Shahryar Sadr and Kassaeian, Sayed Saeed and Danaei, Navid and Gharibi, Farid},
title = {Household’s Catastrophic Health Expenditure in Patients With Type 2 Diabetes: A Study From Iran},
journal = {Health Technology Assessment in Action},
year = {2026},
doi = {10.18502/htaa.v10i2.22222}
}
EUVIMED